,61 In our system, the expression of c-MYC was positively correlated with TP53 and MKI67 expression, consistent with its role as a prognostic biomarker in brain tumors such as gliomas and glioblastomas.62 This evidence concerns the gene MKI67 and central nervous system cancer.